As part of the green transformation of North Rhine-Westphalia’s former coal-mining region, independent assessors have recommended the co-financing of two biotechnology processes developed at pilot scale by Evonik Industries AG, with the aim of advancing them to demonstration scale. The third funding round of the “Produktives.NRW” call includes approximately €70 million from the EU’s Just Transition Fund (JTF) allocated to six projects.
ADVERTISEMENT
Tag Archive for: scaling
The UK government has unveiled a new industrial strategy that includes a commitment to invest £380m in engineering biology. The package comprises an initial £196m for research and development, and a further £184m for the expansion and modernisation of pilot and scale-up infrastructure.
The House of Lords Science and Technology Committee wants to improve technology transfer in industrial biotechnology through better regulation, more funding, and improved access to scale-up infrastructure for biomanufacturing and bioengineering start-ups.
Within the competitive CDMO market, Richter-Helm has developed into a highly valued partner when it comes to the manufacturing of biopharmaceuticals. Richter-Helm is well recognised by pharmaceutical companies, including Big Pharma, as a professional partner offering flexible CDMO solutions from gene to product, all from one source, including consultancy services. This makes Richter-Helm one of the key players in CDMO business.